The following invention is directed to pharmaceutical compounds and compositions of the Formula I
useful for treating conditions mediated by α
v
β
3
and/or α
v
β
5
integrin.
下面的发明是针对化合物和组合物的公式I,用于治疗由αvβ3和/或αvβ5整合素介导的疾病。
WO2006/43930
申请人:——
公开号:——
公开(公告)日:——
NOWICKI, RYSZARD, POL. J. CHEM., 61,(1987) N 1-3, 73-76
作者:NOWICKI, RYSZARD
DOI:——
日期:——
Synthesis of Substituted 4-Aroyl-1-indanone and 5-Aroyl-1-tetralone
作者:Meng-Yang Chang、Nien-Chia Lee
DOI:10.1002/jccs.201190030
日期:2011.6
Several substituted 4‐aroyl‐1‐indanones 2 and 5‐aroyl‐1‐tetralones3 were prepared in good yields from 1‐indanones 1 via a series of reasonable transformations.